Showing results (71-80 of 171) with videos related to
Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Genome-Wide Association Study of Pregnancy in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor StudySeth J Rotz, Sarah Worley, Bo Hu, et al.American Journal of Hematology|October 30, 2014
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantationBetty K Hamilton, Lisa Rybicki, Robert Dean, et al.Transplantation and Cellular Therapy|December 19, 2024
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy DiscontinuationNeel S Bhatt, Andrew C Harris, Lev Gorfinkel, et al.Transplantation and Cellular Therapy|June 28, 2023
Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data InteroperabilityVincent T Ho, Thomas R Klumpp, Wayne H Liang, et al.Transplantation and Cellular Therapy|July 28, 2022
Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare EcosystemJane Koo, Jeffrey J Auletta, David M Hartley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2024
A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host DiseaseVijaya Raj Bhatt, Valerie K Shostrom, Hannah K Choe, et al.American Journal of Hematology|July 1, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" TrialBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.Transplantation and Cellular Therapy|January 24, 2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell TransplantationBlachy J Dávila Saldaña, Kirk R Schultz, Archana Ramgopal, et al.Bone Marrow Transplantation|January 19, 2019
Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromesBetty K Hamilton, Lisa Rybicki, Casandra Hirsch, et al.Pageof 18